Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
474 studies found for:    "Neuroblastoma"
Show Display Options
Rank Status Study
21 Completed Beta-Glucan and Monoclonal Antibody in Treating Patients With Metastatic Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: beta-glucan;   Biological: monoclonal antibody 3F8
22 Completed Iodine I 131 Monoclonal Antibody 3F8 and Bevacizumab in Treating Patients With Relapsed or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: bevacizumab;   Biological: filgrastim;   Procedure: autologous hematopoietic stem cell transplantation;   Radiation: iodine I 131 monoclonal antibody 3F8
23 Completed Combination Chemotherapy Before Surgery in Treating Children With Localized Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: vincristine sulfate;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Procedure: neoadjuvant therapy
24 Active, not recruiting N2007-02:Bevacizumab,Cyclophosphamide,& Zoledronic Acid in Patients W/ Recurrent or Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Bevacizumab;   Drug: cyclophosphamide;   Drug: zoledronic acid
25 Recruiting A Pilot Study of Activated T Cell Therapy for Refractory/Relapsed Neuroblastoma
Condition: Neuroblastoma
Intervention: Biological: Activated T lymphocyte
26 Completed Combination Chemotherapy in Treating Young Patients Who Are Undergoing Surgery and an Autologous Bone Marrow Transplant for Disseminated Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: carboplatin;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: autologous bone marrow transplantation;   Procedure: conventional surgery
27 Completed Monoclonal Antibody Therapy in Treating Children With Metastatic Neuroblastoma in Second Remission
Condition: Neuroblastoma
Intervention: Biological: monoclonal antibody 3F8
28 Completed Biological Therapy and Gene Therapy in Treating Children With Recurrent or Refractory Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: aldesleukin;   Biological: therapeutic autologous lymphocytes;   Drug: chemotherapy;   Drug: ganciclovir
29 Completed Combination Chemotherapy Plus Peripheral Stem Cell Transplantation Followed by Surgery and/or Radiation Therapy in Treating Young Patients With Advanced Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: carboplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: mesna;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET photon therapy
30 Unknown  Chemotherapy and Surgery Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: busulfan;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: melphalan;   Drug: vincristine sulfate;   Procedure: conventional surgery;   Procedure: peripheral blood stem cell transplantation
31 Unknown  Interleukin-2 in Treating Children With Stage IV Neuroblastoma Who Have Received Induction Therapy and Peripheral Stem Cell Transplantation
Condition: Neuroblastoma
Intervention: Biological: aldesleukin
32 Completed N2001-03: CEP-701 in Treating Young Patients With Recurrent or Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: lestaurtinib
33 Unknown  Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: filgrastim;   Drug: doxorubicin hydrochloride;   Drug: topotecan hydrochloride;   Drug: vincristine sulfate
34 Active, not recruiting Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Condition: Neuroblastoma
Intervention: Procedure: tandem high-dose chemotherapy
35 Recruiting Anti-angiogenetic Therapy With Radiotherapy for Pediatric Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: Endostar;   Radiation: 21.6Gy/12Fx to the tumor bed and 36Gy/20Fx to the tumor
36 Active, not recruiting N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: fenretinide;   Other: high performance liquid chromatography;   Other: pharmacological study
37 Completed N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Radiation: UltratraceTM Iobenguane I 131 Imaging;   Radiation: UltratraceTM Iobenguane I 131 Therapy;   Procedure: Peripheral blood stem cell infusion
38 Unknown  Haplo-identical Hematopoietic Stem Cell Transplantation Following Reduced-intensity Conditioning in Children With Neuroblastoma
Condition: Neuroblastoma
Intervention: Drug: Busulfan - Fludarabine - TBI
39 Completed N2004-06: Irinotecan and Vincristine With 131I-MIBG Therapy for Resistant/Relapsed High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Drug: irinotecan hydrochloride;   Drug: vincristine sulfate;   Radiation: iobenguane I 131
40 Completed
Has Results
N2001-02: I-MIBG With Intensive Chemotherapy and Autologous Stem Cell Rescue for High-Risk Neuroblastoma
Condition: Neuroblastoma
Interventions: Biological: Filgrastim;   Drug: Carboplatin;   Drug: Etoposide;   Drug: Melphalan;   Procedure: Peripheral blood stem cell infusion;   Radiation: 131I-MIBG;   Radiation: Radiation therapy

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.